Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J OSBORNE

Showing results (601-610 of 664) with videos related to

Pageof 67
Sort By:
Seminars in Arthritis and Rheumatism|January 3, 2012
HFE C282Y homozygosity is associated with an increased risk of total hip replacement for osteoarthritisYuanyuan Wang, Lyle C Gurrin, Anita E Wluka, et al.
Brain Research|July 19, 2000
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemiaM J O'Neill, T K Murray, D R McCarty, et al.
Journal of Medicinal Chemistry|September 15, 2006
Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profileYanping Xu, Garret J Etgen, Carol L Broderick, et al.
Human Genetics|August 18, 2009
Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulatorsGaia Gestri, Robert J Osborne, Alexander W Wyatt, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2013
The natural history and clinical predictors of egg allergy in the first 2 years of life: a prospective, population-based cohort studyRachel L Peters, Shyamali C Dharmage, Lyle C Gurrin, et al.
Brain Research|January 9, 2001
LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemiaM J O'Neill, C A Hicks, M A Ward, et al.
The Journal of Investigative Dermatology|August 12, 1998
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor geneF Ichii-Jones, J T Lear, A H Heagerty, et al.
Cancer Cell|December 15, 2012
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivoLorena Fontan, Chenghua Yang, Venkataraman Kabaleeswaran, et al.
Transfusion|October 12, 2011
A comparison of self-reported and record-linked blood donation history in an Australian cohortNadine A Bertalli, Katrina J Allen, Christine E McLaren, et al.
Annals of Neurology|August 10, 2013
Splicing biomarkers of disease severity in myotonic dystrophyMasayuki Nakamori, Krzysztof Sobczak, Araya Puwanant, et al.
Pageof 67

Showing results (601-610 of 664) with videos related to

Sort By:
Pageof 67
Seminars in Arthritis and Rheumatism|January 3, 2012
HFE C282Y homozygosity is associated with an increased risk of total hip replacement for osteoarthritisYuanyuan Wang, Lyle C Gurrin, Anita E Wluka, et al.
Brain Research|July 19, 2000
ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemiaM J O'Neill, T K Murray, D R McCarty, et al.
Journal of Medicinal Chemistry|September 15, 2006
Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profileYanping Xu, Garret J Etgen, Carol L Broderick, et al.
Human Genetics|August 18, 2009
Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulatorsGaia Gestri, Robert J Osborne, Alexander W Wyatt, et al.
The Journal of Allergy and Clinical Immunology|December 31, 2013
The natural history and clinical predictors of egg allergy in the first 2 years of life: a prospective, population-based cohort studyRachel L Peters, Shyamali C Dharmage, Lyle C Gurrin, et al.
Brain Research|January 9, 2001
LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemiaM J O'Neill, C A Hicks, M A Ward, et al.
The Journal of Investigative Dermatology|August 12, 1998
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor geneF Ichii-Jones, J T Lear, A H Heagerty, et al.
Cancer Cell|December 15, 2012
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivoLorena Fontan, Chenghua Yang, Venkataraman Kabaleeswaran, et al.
Transfusion|October 12, 2011
A comparison of self-reported and record-linked blood donation history in an Australian cohortNadine A Bertalli, Katrina J Allen, Christine E McLaren, et al.
Annals of Neurology|August 10, 2013
Splicing biomarkers of disease severity in myotonic dystrophyMasayuki Nakamori, Krzysztof Sobczak, Araya Puwanant, et al.
Pageof 67